Investors Center

OUR VALUE PROPOSITION

Gate2Brain is an early-stage biotech company that aims to improve drug delivery across biological barriers using an innovative peptide-based patented technology platform.

Using our technology, our goal is to provide improved permeable, non-antigenic, stable, receptor-specific, soluble, non-invasive, and cost-effective therapeutic candidates with potential applications in a large number of therapeutic fields.


WHY INVEST IN GATE2BRAIN

• An extensive patent portfolio protects our intellectual property rights.

• Our technology platform for the delivery of therapeutics is highly innovative.

• We target the treatment of rare diseases, such as pediatric solid tumors of the central nervous system (brain).

• We are supported by a highly prestigious board and leadership team.

• Our investor partners endorse our discipline in Capital Management.


COMPANY STRATEGY

• To become a world leading company using a cutting-edge delivery technology.

• To provide affordable health solutions.

• To recruit a bold, passionate, fearless and innovative team.

Latest News

Una tecnología para ayudar a tratar el cáncer infantilgate2brain
This past October, the i4KIDS Pediatric Innovation Hub hosted the Pediatric Innovation Day. Here is a video from Gate2Brain introducing its technology for pediatric brain tumors as one of the six finalist projects in the innovation competition. This fantastic and valuable initiative is organized by i4KIDS, an innovation-support Hub intended to identify pediatric and maternal health projects with the greatest potential in order to bring them closer to the market. The Hub is coordinated by Sant Joan de Déu Barcelona Children’s Hospital, In 2021, the #PediatricInnovationDay showcased some of the many innovative and challenging projects that are currently carried out in the field of pediatrics.

Let’s start a conversation

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.